| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,700 |
2,074 |
$128K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,134 |
1,768 |
$69K |
| 99401 |
|
2,329 |
1,736 |
$47K |
| 99215 |
Prolong outpt/office vis |
515 |
451 |
$37K |
| 99205 |
Prolong outpt/office vis |
307 |
235 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,084 |
896 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
331 |
286 |
$15K |
| 99402 |
|
422 |
365 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
688 |
492 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
560 |
477 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
214 |
194 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
203 |
177 |
$8K |
| A4927 |
Gloves, non-sterile, per 100 |
1,043 |
882 |
$7K |
| 86769 |
|
218 |
193 |
$7K |
| 86328 |
|
199 |
177 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
510 |
441 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,635 |
1,622 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
78 |
71 |
$4K |
| 92558 |
|
256 |
239 |
$4K |
| 96127 |
|
732 |
548 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
63 |
57 |
$3K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
71 |
65 |
$2K |
| 99406 |
|
270 |
219 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
82 |
78 |
$2K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
31 |
24 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
94 |
85 |
$1K |
| 87634 |
|
28 |
25 |
$1K |
| 36416 |
|
286 |
247 |
$960.25 |
| 87807 |
|
106 |
102 |
$860.56 |
| 99385 |
|
24 |
14 |
$736.80 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
28 |
24 |
$661.14 |
| 90686 |
|
29 |
28 |
$434.23 |
| 87077 |
|
130 |
108 |
$388.98 |
| 86580 |
|
71 |
67 |
$362.10 |
| 81003 |
|
204 |
185 |
$257.30 |
| 96161 |
|
110 |
106 |
$237.51 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
15 |
14 |
$186.28 |
| 85018 |
|
130 |
120 |
$177.84 |
| 92551 |
|
25 |
25 |
$152.00 |
| 81002 |
|
67 |
57 |
$134.54 |
| 82947 |
|
71 |
54 |
$123.09 |
| 90688 |
|
13 |
12 |
$122.88 |
| 99173 |
|
28 |
26 |
$57.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
34 |
25 |
$36.74 |
| 87070 |
|
20 |
20 |
$19.41 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12 |
12 |
$14.74 |
| 94760 |
|
267 |
156 |
$0.87 |
| 91300 |
|
31 |
31 |
$0.29 |
| 99072 |
|
96 |
77 |
$0.00 |
| 99001 |
|
76 |
56 |
$0.00 |
| 98960 |
|
38 |
30 |
$0.00 |
| 99071 |
|
28 |
20 |
$0.00 |
| 99070 |
|
245 |
122 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
12 |
12 |
$0.00 |